The last few years have witnessed the increasing use of bisphosphonates and at the 14th European Congress of Rheumatology [Glasgow, UK; June 1999] Merck Sharp & Dohme sponsored a symposium presenting the latest results on its bisphosphonate, alendronic acid [alendronate].